Please wait while the formulary information is being retrieved.
Drug overview for DECUB-AMINE (whey protein concentrate/arginine/glutamine/flaxseed):
Generic name: WHEY PROTEIN CONCENTRATE/ARGININE/GLUTAMINE/FLAXSEED
Drug class:
Therapeutic class: Electrolyte Balance-Nutritional Products
No enhanced Introduction information available for this drug.
No enhanced Uses information available for this drug.
Generic name: WHEY PROTEIN CONCENTRATE/ARGININE/GLUTAMINE/FLAXSEED
Drug class:
Therapeutic class: Electrolyte Balance-Nutritional Products
No enhanced Introduction information available for this drug.
No enhanced Uses information available for this drug.
DRUG IMAGES
No Image Available
The following indications for DECUB-AMINE (whey protein concentrate/arginine/glutamine/flaxseed) have been approved by the FDA:
Indications:
None.
Professional Synonyms:
None.
Indications:
None.
Professional Synonyms:
None.
The following dosing information is available for DECUB-AMINE (whey protein concentrate/arginine/glutamine/flaxseed):
No enhanced Dosing information available for this drug.
No enhanced Administration information available for this drug.
No dosing information available.
No generic dosing information available.
The following drug interaction information is available for DECUB-AMINE (whey protein concentrate/arginine/glutamine/flaxseed):
There are 0 contraindications.
There are 2 severe interactions.
These drug interactions can produce serious consequences in most patients. Actions required for severe interactions include, but are not limited to, discontinuing one or both agents, adjusting dosage, altering administration scheduling, and providing additional patient monitoring. Review the full interaction monograph for more information.
| Drug Interaction | Drug Names |
|---|---|
| Exagamglogene Autotemcel/Disease Modifying Agents SEVERITY LEVEL: 2-Severe Interaction: Action is required to reduce the risk of severe adverse interaction. MECHANISM OF ACTION: The interaction potential of disease modifying agents with exagamglogene autotemcel is unknown.(1) CLINICAL EFFECTS: Disease modifying agents may interfere with exagamglogene autotemcel therapy.(1) PREDISPOSING FACTORS: None determined. PATIENT MANAGEMENT: Discontinue disease modifying therapies for sickle cell disease (e.g. voxelotor, crizanlizumab) at least 8 weeks prior to the start of mobilization.(1) It is recommended that patients be transfused at least 8 weeks prior to the initiation of myeloablative conditioning. At initiation of red blood cell exchange or simple transfusions, discontinue disease modifying therapies for sickle cell disease (e.g. voxelotor, crizanlizumab).(1) DISCUSSION: There is no experience with the use of disease modifying agents with exagamglogene autotemcel infusion.(1) |
CASGEVY |
| Lovotibeglogene Autotemcel/Disease Modifying Agents SEVERITY LEVEL: 2-Severe Interaction: Action is required to reduce the risk of severe adverse interaction. MECHANISM OF ACTION: The interaction potential of disease modifying agents with lovotibeglogene autotemcel is unknown.(1) CLINICAL EFFECTS: Disease modifying agents may interfere with lovotibeglogene autotemcel therapy.(1) PREDISPOSING FACTORS: None determined. PATIENT MANAGEMENT: Discontinue disease modifying therapies (e.g. voxelotor, crizanlizumab) for sickle cell disease at least 8 weeks prior to start of mobilization and conditioning.(1) DISCUSSION: There is no experience with the use of disease modifying agents with lovotibeglogene autotemcel infusion.(1) |
LYFGENIA |
There are 0 moderate interactions.
The following contraindication information is available for DECUB-AMINE (whey protein concentrate/arginine/glutamine/flaxseed):
Drug contraindication overview.
No enhanced Contraindications information available for this drug.
No enhanced Contraindications information available for this drug.
There are 5 contraindications.
Absolute contraindication.
| Contraindication List |
|---|
| Appendicitis |
| Esophageal obstruction |
| Gastrointestinal obstruction |
| Paralytic ileus |
| Pyloroduodenal obstruction |
There are 0 severe contraindications.
There are 1 moderate contraindications.
Clinically significant contraindication, where the condition can be managed or treated before the drug may be given safely.
| Moderate List |
|---|
| Inflammatory bowel disease |
The following adverse reaction information is available for DECUB-AMINE (whey protein concentrate/arginine/glutamine/flaxseed):
Adverse reaction overview.
No enhanced Common Adverse Effects information available for this drug.
No enhanced Common Adverse Effects information available for this drug.
There are 1 severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
| None. | None. |
| Rare/Very Rare |
|---|
|
Neuropsychiatric disorder |
There are 18 less severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
|
Acute abdominal pain Constipation Cough Flatulence Headache disorder Nausea |
Abdominal distension Abnormal hepatic function tests Back pain Chest pain Diarrhea Nausea Pain in extremities Vomiting |
| Rare/Very Rare |
|---|
|
Behavioral disorders Constipation Dyspepsia Hypertriglyceridemia |
The following precautions are available for DECUB-AMINE (whey protein concentrate/arginine/glutamine/flaxseed):
No enhanced Pediatric Use information available for this drug.
Contraindicated
Severe Precaution
Management or Monitoring Precaution
Contraindicated
| None |
Severe Precaution
| None |
Management or Monitoring Precaution
| None |
No enhanced Pregnancy information available for this drug.
No enhanced Lactation information available for this drug.
No enhanced Geriatric Use information available for this drug.
The following prioritized warning is available for DECUB-AMINE (whey protein concentrate/arginine/glutamine/flaxseed):
No warning message for this drug.
No warning message for this drug.
The following icd codes are available for DECUB-AMINE (whey protein concentrate/arginine/glutamine/flaxseed)'s list of indications:
No ICD codes found for this drug.
No ICD codes found for this drug.
Formulary Reference Tool